Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript

·38-min read
Flexion Therapeutics Inc (FLXN) Q1 2021 Earnings Call Transcript

In addition, today, we are introducing refreshed metrics to provide increased visibility and insights into the commercial performance of ZILRETTA. Today's discussion will be led by Flexion's Chief Executive Officer, Dr. Michael Clayman, and he's joined by Melissa Layman, Flexion's Chief Commercial Officer; and David Arkowitz, Flexion's Chief Financial Officer.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting